Oil Tycoon T. Boone Pickens Left Behind an Incredible Letter About the Best Life Lessons He Learned, and Every Line is a Must-read (Business Insider)......
(read more)September 20 - Hedge Funds, Insider Trading - Comments
Elliott Management Advocated for an Allergan Split Prior to Sale (Bloomberg) Elliott Management Corp. had built a position in Allergan Plc and was pushing......
(read more)June 26 - Hedge Funds, Insider Trading - Comments
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher......
(read more)December 7 - Dividend Stocks, Hedge Funds, News - Comments
George Soros Bought These 2 Healthcare Stocks in the Third Quarter (The Motley Fool) Although billionaire superinvestor George Soros may no longer be......
(read more)December 3 - Hedge Funds, Insider Trading - Comments
Omeros Corporation (NASDAQ:OMER) (MarketWatch) Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government......
(read more)March 22 - Market Movers, News - Comments
Elliott Buys Tiny Stake in Wipro in First India IT Firm Holding (Bloomberg) Billionaire Paul Singer’s Elliott Management Corp. has bought a stake in......
(read more)March 12 - Hedge Funds, Insider Trading - Comments
There is no doubt that the marijuana industry in the US has a lot of growth potential. The sale of medical and recreational weed is expected to reach $......
(read more)February 22 - Commodities, Hedge Funds, News - Comments
Devon Energy Corp (NYSE:DVN) (MarketWatch) Shares of Devon Energy Corp. DVN, -10.16% fell 6% in premarket trading Wednesday, after the company posted......
(read more)February 21 - Market Movers, News - Comments
AbbVie Inc (NYSE:ABBV) (CNBC) AbbVie, the maker of the world’s best selling drug, reported fourth-quarter profit on Friday that beat Wall Street......
(read more)January 26 - Market Movers, News - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest......
(read more)November 24 - News - Comments
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and......
(read more)November 23 - News - Comments
You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which......
(read more)May 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators. Technology paints......
(read more)April 5 - Lists, News - Comments
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court. The ruling was in favor......
(read more)March 6 - News, Stock Analysis - Comments
The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program......
(read more)February 21 - News, Stock Analysis - Comments
The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)‘s Venclyxto on NHS. Besides the price, the......
(read more)February 16 - News, Stock Analysis - Comments
AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really......
(read more)January 20 - News, Stock Analysis - Comments
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies. Just keep on reading......
(read more)January 12 - Lists, News - Comments
AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC. The collaboration......
(read more)January 10 - News, Stock Analysis - Comments
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed......
(read more)January 3 - News, Stock Analysis - Comments
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros. Ranked 128th on Forbes’ list of the richest people......
(read more)December 23 - Dividend Stocks, Hedge Funds, News - Comments
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration......
(read more)December 21 - News, Stock Analysis - Comments
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing. The fund has a heavy......
(read more)December 16 - Hedge Funds, News - Comments
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr. Robbins worked in Leon......
(read more)December 2 - Hedge Fund Analysis, Hedge Funds, News - Comments
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (......
(read more)November 29 - News, Stock Analysis - Comments
The final ‘stock considerations’ post of 2016 is finally at hand. At the beginning of the year it’s sometimes hard to imagine what the next twelve......
(read more)November 28 - Dividend Stocks, News, Stock Analysis - Comments
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent......
(read more)November 9 - News - Comments
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today. While both were trading......
(read more)November 7 - Market Movers, News, Stock Analysis - Comments
As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have......
(read more)November 1 - Dividend Stocks, News, Stock Analysis - Comments
Despite the fact that the polls are narrowing and November 8 is just over a week away, the markets are rather calm, as all three indexes are moderately......
(read more)October 31 - Market Movers, News - Comments
I usually look at dividend growth stocks and their dividend increases every week, as part of my portfolio monitoring process. In this weekly review,......
(read more)October 31 - Dividend Stocks, News, Stock Analysis - Comments
I always end my ‘Recent Buys’ posts with the caveat that Mr. Market can always spring up some new opportunities not outlined in my monthly considerations......
(read more)October 31 - Dividend Stocks, News - Comments
Although the fundamental prospects for many companies are strong given the robust U.S. economy and low unemployment rate, some analysts became quite a......
(read more)September 6 - Market Movers, News - Comments
AbbVie Inc (NYSE:ABBV) and Biogen Inc (NASDAQ:BIIB) drug Zinbryta was approved by the Food and Drug Administration (FDA) as a therapy for adults suffering......
(read more)August 26 - News, Stock Analysis - Comments
The Nasdaq and all other major indexes are in the red this morning despite tech heavyweights Amazon.com, Inc. (NASDAQ:AMZN) and Alphabet Inc (NASDAQ......
(read more)July 29 - Earnings Report, Market Movers, News - Comments
Today, long term investors are challenged in navigating the course and lining up that long drive for a investment that will provide them a better than......
(read more)June 29 - Dividend Stocks, News, Stock Analysis - Comments
After opening flat, the three indexes have sold off again. The Dow, S&P and NASDAQ are each off around 0.6%, while crude futures are down twice as......
(read more)June 14 - News - Comments
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish. However, some......
(read more)June 6 - Market Movers, News - Comments
Oil baron and America’s first billionaire John D. Rockefeller once said, ‘do you know the only thing that gives me pleasure? It’s to......
(read more)May 28 - Dividend Stocks, Hedge Funds, News - Comments
Larry Robbins‘ Glenview Capital has been underperforming the broader market and the overall hedge fund industry for over a year now. However, this......
(read more)May 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......
(read more)May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets are trading in the red today after investor sentiment was dented following the Labor Department’s assertion that the U.S economy inched......
(read more)April 28 - Market Movers, News - Comments
Syracuse University graduate Richard L. Haydon named his fund after the Tipperary Hill area, his childhood neighborhood. Before establishing Tipp Hill......
(read more)April 26 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China’......
(read more)April 12 - Market Movers, News - Comments
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central......
(read more)March 15 - News - Comments
After years of low interest rates, retail investors continue to starve for income while awaiting higher yields. The long-lasting low interest rate environment......
(read more)March 8 - Hedge Funds, News - Comments
Amid the latest market volatility, dividend investing is one of the safest bets on the equity markets. Large investors select dividend stocks not just......
(read more)March 5 - Dividend Stocks, Hedge Funds, News - Comments
AbbVie Inc (NYSE:ABBV) is one of the more controversial dividend aristocrats for several reasons. As a relatively new spin-off (2013), the company has......
(read more)March 3 - Dividend Stocks, News, Stock Analysis - Comments
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few......
(read more)March 1 - Hedge Fund Analysis, Hedge Funds, News - Comments
